Rosen, nationally regarded investor counsel, encourages sonoma pharmaceuticals, inc. investors with losses to inquire about securities class action investigation – snoa

New york--(business wire)--why: rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of sonoma pharmaceuticals, inc. (nasdaq: snoa) resulting from allegations that sonoma may have issued materially misleading business information to the investing public. so what: if you purchased sonoma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen
SNOA Ratings Summary
SNOA Quant Ranking